Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹168 Cr
up ₹10.5 Cr vs Dec 2018
- Stocks held
- 23
- up 2 vs Dec 2018
- Top 10 weight
- 51.6%
- of the portfolio in its ten largest
- Cash & debt
- 19.5%
- cash, money market and debt
- Moves this month
- 2 in · 0 out
- added to 10, trimmed 3
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In January 2019 it disclosed 23 stocks worth ₹168 Cr, up ₹10.5 Cr from Dec 2018. Its largest positions were Sun Pharmaceutical Industries Limited (7.4%), IPCA Laboratories Limited (7.1%), Dr. Reddy's Laboratories Limited (6.7%); the ten largest together made up 51.6% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 72.9% of its equity. Cash and debt stood at 19.5%. Compared with Dec 2018 the fund entered 2 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
62%
Top-10 weight is higher than 62% of peers
Breadth
6%
Holds more stocks than 6% of peers
Cash
99%
Holds more cash than 99% of peers
What these mean: concentration · cash
Holdings in January 2019
Download CSVEvery line the fund disclosed, with the change against Dec 2018. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Cash, TREPS & receivables | 19.47% | down 9.08 pts | ₹32.7 Cr | down ₹12.3 Cr | Trimmed |
| Sun Pharmaceutical Industries Limited | 7.42% | up 0.88 pts | ₹12.5 Cr | up ₹2.2 Cr | Added |
| IPCA Laboratories Limited | 7.12% | up 0.99 pts | ₹12 Cr | up ₹2.3 Cr | Added |
| Dr. Reddy's Laboratories Limited | 6.71% | up 1.38 pts | ₹11.3 Cr | up ₹2.9 Cr | Added |
| Alkem Laboratories Limited | 5.10% | down 0.43 pts | ₹8.6 Cr | down ₹14 L | Trimmed |
| Divi's Laboratories Limited | 4.76% | up 0.78 pts | ₹8 Cr | up ₹1.7 Cr | Added |
| Max India Limited | 4.21% | down 0.28 pts | ₹7.1 Cr | — | Held |
| JB Chemicals & Pharmaceuticals Limited | 4.15% | up 0.14 pts | ₹7 Cr | up ₹66 L | Added |
| Apollo Hospitals Enterprise Limited | 4.06% | up 0.05 pts | ₹6.8 Cr | up ₹51 L | Added |
| Unichem Laboratories Limited | 4.03% | up 0.18 pts | ₹6.8 Cr | up ₹71 L | Added |
| Indoco Remedies Limited | 4.00% | up 0.18 pts | ₹6.7 Cr | up ₹70 L | Added |
| Aarti Drugs Limited | 3.15% | up 0.17 pts | ₹5.3 Cr | up ₹59 L | Added |
| Procter & Gamble Health Limited | 3.15% | up 3.15 pts | ₹5.3 Cr | up ₹5.3 Cr | New |
| Jubilant Pharmova Limited | 2.98% | up 0.50 pts | ₹5 Cr | up ₹1.1 Cr | Added |
| Alembic Pharmaceuticals Limited | 2.97% | down 0.12 pts | ₹5 Cr | up ₹12 L | Added |
| Torrent Pharmaceuticals Limited | 2.76% | down 0.11 pts | ₹4.6 Cr | up ₹12 L | Added |
| Ajanta Pharma Limited | 2.54% | down 0.50 pts | ₹4.3 Cr | down ₹53 L | Trimmed |
| Abbott India Limited | 2.03% | up 2.03 pts | ₹3.4 Cr | up ₹3.4 Cr | New |
| Syngene International Limited | 2.00% | up 0.04 pts | ₹3.4 Cr | up ₹27 L | Added |
| Lupin Limited | 1.99% | up 0.08 pts | ₹3.3 Cr | up ₹33 L | Added |
| ICICI Lombard General Insurance Company Limited | 1.95% | up 0.01 pts | ₹3.3 Cr | up ₹22 L | Added |
| Cipla Limited | 1.65% | down 0.12 pts | ₹2.8 Cr | down ₹1 L | Held |
| Dr. Lal Path Labs Limited | 1.57% | up 0.16 pts | ₹2.6 Cr | up ₹41 L | Added |
| Sun Pharma Advanced Research Company Limited | 0.22% | down 0.06 pts | ₹37 L | down ₹7 L | Trimmed |
What changed, Dec 2018 to Jan 2019
New New positions (2)
- Procter & Gamble Health Limited3.1% · ₹5.3 Cr
- Abbott India Limited2.0% · ₹3.4 Cr
Exited Exited (0)
None.
Added Biggest additions
- Dr. Reddy's Laboratories Limitedup ₹2.9 Cr (+1.38% pts)
- IPCA Laboratories Limitedup ₹2.3 Cr (+0.99% pts)
- Sun Pharmaceutical Industries Limitedup ₹2.2 Cr (+0.88% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Dec 2018, the weight rose most in Pharmaceuticals & Biotechnology (+3.0 pts), and fell most in Healthcare Services (−1.9 pts) and Pharmaceuticals (−0.8 pts).
- Pharmaceuticals & Biotechnology69.9% → 72.9%+3.0 pts
- Healthcare Services16.6% → 14.7%−1.9 pts
- Pharmaceuticals10.7% → 10.0%−0.8 pts
- Insurance2.7% → 2.4%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Dec 2018 | Jan 2019 |
|---|---|---|
| Pharmaceuticals & Biotechnology | 69.9% | 72.9% |
| Healthcare Services | 16.6% | 14.7% |
| Pharmaceuticals | 10.7% | 10.0% |
| Insurance | 2.7% | 2.4% |
Allocation in Jan 2019change vs Dec 2018
- Pharmaceuticals & Biotechnology (16)72.9%▲ 3.0 pts
- Healthcare Services (4)14.7%▼ 1.9 pts
- Pharmaceuticals (2)10.0%▼ 0.8 pts
- Insurance (1)2.4%▼ 0.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jan 2019
19.5%
▼ 9.1 pts vs Dec 2018
- Cash alone
- 19.5%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 19.5% – 28.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.